source stringlengths 2 222 | date stringlengths 19 19 | url stringlengths 22 853 ⌀ | text stringlengths 0 10k ⌀ | title stringlengths 0 701 | context_id stringlengths 1 9 | document_id stringclasses 2
values | document_type stringclasses 2
values |
|---|---|---|---|---|---|---|---|
ANALYSTRATINGS | 2020-04-30 14:29:15 | https://www.analystratings.com/articles/analysts-offer-insights-on-healthcare-companies-universal-health-nyse-uhs-deciphera-pharmaceuticals-nasdaq-dcph-and-constellation-pharmaceuticals-nasdaq-cnst/ | There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Universal Health (
UHS
–
Research Report
), Deciphera Pharmaceuticals (
DCPH
–
Research Report
) and Constellation Pharmaceuticals (
CNST
–
Research Report | Analysts Offer Insights on Healthcare Companies: Universal Health (NYSE: UHS), Deciphera Pharmaceuticals (NASDAQ: DCPH) and Constellation Pharmaceuticals (NASDAQ: CNST) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-30 13:55:30 | https://www.smarteranalyst.com/new-blurbs/credit-suisse-maintains-their-buy-rating-on-service-international-sci/ | Credit Suisse analyst A.J. Rice maintained a Buy rating on Service International (SCI) today and set a price target of $43.00. The company's shares closed | Credit Suisse Maintains Their Buy Rating on Service International (SCI) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-29 16:24:25 | https://www.smarteranalyst.com/new-blurbs/credit-suisse-maintains-their-sell-rating-on-community-health-cyh/ | In a report released yesterday, A.J. Rice from Credit Suisse maintained a Sell rating on Community Health (CYH), with a price target of $2.40. The | Credit Suisse Maintains Their Sell Rating on Community Health (CYH) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
MARKETS | 2020-04-29 16:24:21 | https://www.markets.co/credit-suisse-maintains-their-sell-rating-on-community-health-cyh/250734/ | In a report released yesterday, A.J. Rice from Credit Suisse maintained a Sell rating on Community Health (CYH – Research | Credit Suisse Maintains Their Sell Rating on Community Health (CYH) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-29 16:24:15 | https://www.smarteranalyst.com/new-blurbs/centene-cnc-receives-a-hold-from-credit-suisse/ | In a report released yesterday, A.J. Rice from Credit Suisse maintained a Hold rating on Centene (CNC), with a price target of $72.50. The company's | Centene (CNC) Receives a Hold from Credit Suisse | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
ANALYSTRATINGS | 2020-04-29 16:24:11 | https://www.analystratings.com/articles/centene-cnc-receives-a-hold-from-credit-suisse/ | In a report released yesterday,
A.J. Rice
from Credit Suisse maintained a
Hold
rating on Centene (
CNC
–
Research Report
), with a price target of
$72.50
. The company’s shares closed last Wednesday at $67.75.
According to
TipRanks.com
, Rice is a 4- | Centene (CNC) Receives a Hold from Credit Suisse | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-29 16:23:28 | https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-healthcare-companies-livanova-livn-crispr-therapeutics-ag-crsp-and-encompass-health-ehc/ | There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on LivaNova (LIVN), Crispr Therapeutics AG (CRSP) and | Analysts Offer Insights on Healthcare Companies: LivaNova (LIVN), Crispr Therapeutics AG (CRSP) and Encompass Health (EHC) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
MARKETS | 2020-04-29 16:23:24 | https://www.markets.co/analysts-offer-insights-on-healthcare-companies-livanova-nasdaq-livn-crispr-therapeutics-ag-nasdaq-crsp-and-encompass-health-nyse-ehc/250732/ | There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on LivaNova (LIVN | Analysts Offer Insights on Healthcare Companies: LivaNova (NASDAQ: LIVN), Crispr Therapeutics AG (NASDAQ: CRSP) and Encompass Health (NYSE: EHC) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-28 18:36:54 | https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-healthcare-companies-universal-health-uhs-and-teladoc-tdoc/ | Analysts have been eager to weigh in on the Healthcare sector with new ratings on Universal Health (UHS) and Teladoc (TDOC). Universal Health (UHS) Credit | Analysts Offer Insights on Healthcare Companies: Universal Health (UHS) and Teladoc (TDOC) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
MARKETS | 2020-04-28 18:36:50 | https://www.markets.co/analysts-offer-insights-on-healthcare-companies-universal-health-nyse-uhs-and-teladoc-nyse-tdoc/250446/ | Analysts have been eager to weigh in on the Healthcare sector with new ratings on Universal Health (UHS – Research | Analysts Offer Insights on Healthcare Companies: Universal Health (NYSE: UHS) and Teladoc (NYSE: TDOC) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
INVESTORPLACE | 2020-04-28 15:00:56 | https://investorplace.com/2020/04/10-stocks-to-buy-for-an-aging-population/ | Aging seniors have been put firmly in the crosshairs of the novel coronavirus. These 10 stocks to buy will benefit from this brutal reality. | 10 Stocks to Buy for an Aging Population | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
ZACKS | 2020-04-27 16:31:55 | https://www.zacks.com/stock/news/892383/earnings-preview-acadia-healthcare-achc-q1-earnings-expected-to-decline | Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. | Earnings Preview: Acadia Healthcare (ACHC) Q1 Earnings Expected to Decline | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-04-27 16:31:04 | https://finance.yahoo.com/news/earnings-preview-acadia-healthcare-achc-163104796.html?.tsrc=rss | Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. | Earnings Preview: Acadia Healthcare (ACHC) Q1 Earnings Expected to Decline | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
TALKMARKETS | 2020-04-27 13:06:38 | https://talkmarkets.com/content/us-markets/stocks-are-set-to-rise-on-april-27-but-are-going-nowhere-fast?post=259994 | The good news is that stocks are pointing to a higher opening on April 27. | Stocks Are Set To Rise On April 27 But Are Going Nowhere Fast | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
THELINCOLNIANONLINE | 2020-04-27 09:52:45 | https://www.thelincolnianonline.com/2020/04/27/acadia-healthcare-company-inc-nasdaqachc-expected-to-announce-earnings-of-0-38-per-share.html | Equities research analysts expect Acadia Healthcare Company Inc (NASDAQ:ACHC) to post $0.38 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Six analysts have made estimates for Acadia Healthcare’s earnings, with estimates ranging from $0.32 to $0.41. Acadia Healthcare reported earni... | Acadia Healthcare Company Inc (NASDAQ:ACHC) Expected to Announce Earnings of $0.38 Per Share | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
THELINCOLNIANONLINE | 2020-04-27 08:22:42 | https://www.thelincolnianonline.com/2020/04/27/acadia-healthcare-achc-scheduled-to-post-quarterly-earnings-on-monday.html | Acadia Healthcare (NASDAQ:ACHC) is scheduled to be issuing its quarterly earnings data after the market closes on Monday, May 4th. Analysts expect the company to announce earnings of $0.39 per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link. ... | Acadia Healthcare (ACHC) Scheduled to Post Quarterly Earnings on Monday | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-27 02:43:26 | https://www.smarteranalyst.com/new-blurbs/analysts-are-bullish-on-these-financial-stocks-herc-holdings-hri-american-express-axp/ | There's a lot to be optimistic about in the Financial sector as 3 analysts just weighed in on Herc Holdings (HRI), American Express (AXP) and Ehealth | Analysts Are Bullish on These Financial Stocks: Herc Holdings (HRI), American Express (AXP) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga Newsdesk | 2020-04-27 00:00:00 | https://www.benzinga.com/wiim/20/04/15887344/shares-of-several-healthcare-companies-are-trading-higher-as-equities-gain-strength-on-news-that-som | Shares of several healthcare companies are trading higher as equities gain strength on news that some U.S. states will reopen their economies in phases, increasing economic activity and optimism around the coronavirus pandemic. | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
THELINCOLNIANONLINE | 2020-04-26 09:40:48 | https://www.thelincolnianonline.com/2020/04/26/jpmorgan-chase-co-downgrades-acadia-realty-trust-nyseakr-to-underweight.html | JPMorgan Chase & Co. cut shares of Acadia Realty Trust (NYSE:AKR) from a neutral rating to an underweight rating in a research note released on Wednesday, BenzingaRatingsTable reports. The firm currently has $13.00 price target on the real estate investment trust’s stock. Several other brokerages also recently commente... | JPMorgan Chase & Co. Downgrades Acadia Realty Trust (NYSE:AKR) to Underweight | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
THELINCOLNIANONLINE | 2020-04-26 05:18:41 | https://www.thelincolnianonline.com/2020/04/26/analysts-anticipate-acadia-healthcare-company-inc-nasdaqachc-will-announce-quarterly-sales-of-795-88-million.html | Brokerages forecast that Acadia Healthcare Company Inc (NASDAQ:ACHC) will report sales of $795.88 million for the current fiscal quarter, according to Zacks Investment Research. Six analysts have provided estimates for Acadia Healthcare’s earnings. The lowest sales estimate is $780.67 million and the highest is $803.93... | Analysts Anticipate Acadia Healthcare Company Inc (NASDAQ:ACHC) Will Announce Quarterly Sales of $795.88 Million | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
THELINCOLNIANONLINE | 2020-04-25 09:04:41 | https://www.thelincolnianonline.com/2020/04/25/acadia-healthcare-company-inc-nasdaqachc-given-average-rating-of-hold-by-brokerages.html | Acadia Healthcare Company Inc (NASDAQ:ACHC) has earned a consensus recommendation of “Hold” from the twelve research firms that are currently covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rat... | Acadia Healthcare Company Inc (NASDAQ:ACHC) Given Average Rating of "Hold" by Brokerages | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-04-25 02:50:00 | https://finance.yahoo.com/news/acadia-healthcare-investigation-initiated-former-025000003.html?.tsrc=rss | Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Acadia Healthcare Company, Inc. (NasdaqGS: ACHC). | ACADIA HEALTHCARE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Acadia Healthcare Company, Inc. - ACHC | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
BARRONS | 2020-04-25 01:35:00 | https://www.barrons.com/articles/in-a-stock-market-like-this-anything-could-cause-the-next-panic-heres-what-to-watch-51587776542 | The longer the coronavirus keeps a lid on economic activity, the greater the potential that anything could become the next flashpoint. | In a Stock Market Like This, Anything Could Cause the Next Panic. Here’s What to Watch. | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SIMPLYWALL | 2020-04-24 10:07:53 | https://simplywall.st/stocks/us/healthcare/nasdaq-achc/acadia-healthcare-company/news/why-acadia-healthcare-company-inc-nasdaqachc-could-be-worth-watching/ | Acadia Healthcare Company, Inc. (NASDAQ:ACHC), which is in the healthcare business, and is based in United States, saw... | Why Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Could Be Worth Watching | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-04-23 20:30:00 | https://finance.yahoo.com/news/acadia-healthcare-announces-change-annual-203000472.html?.tsrc=rss | Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced a change in the format for the Company’s 2020 Annual Meeting of Stockholders (the "Annual Meeting") via the filing of additional proxy materials with the Securities and Exchange Commission. Due to the evolving public health impact of the COVID-19 pandemic, ... | Acadia Healthcare Announces Change in Annual Meeting Location to Virtual Format | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-04-22 22:05:10 | https://finance.yahoo.com/m/3566fed0-f384-35f5-adab-a3f71ee404eb/acadia-healthcare-company%2C.html?.tsrc=rss | Moody's Investors Service (Moody's) downgraded the ratings of Acadia Healthcare Company, Inc. ("Acadia"), including the Corporate Family Rating (CFR) to B2 from B1 and the Probability of Default Rating to B2-PD from B1-PD. Moody's also downgraded the Speculative Grade Liquidity Rating to SGL-3 from SGL-2 and changed t... | Acadia Healthcare Company, Inc. -- Moody's downgrades Acadia Healthcare Company's CFR to B2 from B1; outlook stable | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-22 15:51:24 | https://www.smarteranalyst.com/new-blurbs/hca-healthcare-hca-received-its-third-buy-in-a-row-2/ | After Barclays and Robert W. Baird gave HCA Healthcare (NYSE: HCA) a Buy rating last month, the company received another Buy, this time from RBC Capital. | HCA Healthcare (HCA) Received its Third Buy in a Row | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-04-22 15:00:00 | https://finance.yahoo.com/news/acadia-healthcare-launches-national-behavioral-150000251.html?.tsrc=rss | Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today launched a national behavioral health crisis hotline designed to offer urgent assistance to anyone across the country who is in need of mental health or addiction services. Individuals can call 1-833-TREATBH (873-2824) toll-free to be immediately connected to the beh... | Acadia Healthcare Launches National Behavioral Health Crisis Hotline | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
THELINCOLNIANONLINE | 2020-04-21 09:46:53 | https://www.thelincolnianonline.com/2020/04/21/exane-derivatives-makes-new-investment-in-acadia-healthcare-company-inc-nasdaqachc.html | Exane Derivatives bought a new position in shares of Acadia Healthcare Company Inc (NASDAQ:ACHC) during the 1st quarter, Holdings Channel.com reports. The firm bought 3,268 shares of the company’s stock, valued at approximately $60,000. A number of other institutional investors and hedge funds also recently made change... | Exane Derivatives Makes New Investment in Acadia Healthcare Company Inc (NASDAQ:ACHC) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-20 13:35:01 | https://www.smarteranalyst.com/new-blurbs/brookdale-bkd-receives-a-hold-from-rbc-capital/ | In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Brookdale (BKD), with a price target of $4.00. The company's shares | Brookdale (BKD) Receives a Hold from RBC Capital | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
MARKETS | 2020-04-20 13:34:56 | https://www.markets.co/brookdale-bkd-receives-a-hold-from-rbc-capital/248888/ | In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Brookdale (BKD – Research Report), | Brookdale (BKD) Receives a Hold from RBC Capital | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-20 13:34:50 | https://www.smarteranalyst.com/new-blurbs/rbc-capital-remains-a-buy-on-surgery-partners-sgry/ | In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Surgery Partners (SGRY), with a price target of $14.00. The company's | RBC Capital Remains a Buy on Surgery Partners (SGRY) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
ANALYSTRATINGS | 2020-04-20 13:34:47 | https://www.analystratings.com/articles/rbc-capital-remains-a-buy-on-surgery-partners-sgry/ | In a report released today,
Frank Morgan
from RBC Capital maintained a
Buy
rating on Surgery Partners (
SGRY
–
Research Report
), with a price target of
$14.00
. The company’s shares closed last Monday at $9.80.
According to
TipRanks.com
, Morgan is | RBC Capital Remains a Buy on Surgery Partners (SGRY) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-20 13:34:41 | https://www.smarteranalyst.com/new-blurbs/rbc-capital-remains-a-buy-on-select-medical-sem/ | RBC Capital analyst Frank Morgan maintained a Buy rating on Select Medical (SEM) today and set a price target of $26.00. The company's shares closed last | RBC Capital Remains a Buy on Select Medical (SEM) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
ANALYSTRATINGS | 2020-04-20 13:34:38 | https://www.analystratings.com/articles/rbc-capital-remains-a-buy-on-select-medical-sem/ | RBC Capital analyst
Frank Morgan
maintained a
Buy
rating on Select Medical (
SEM
–
Research Report
) today and set a price target of
$26.00
. The company’s shares closed last Monday at $16.00.
According to
TipRanks.com
, Morgan is a 5-star analyst wi | RBC Capital Remains a Buy on Select Medical (SEM) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-20 13:34:30 | https://www.smarteranalyst.com/new-blurbs/pennant-group-pntg-gets-a-hold-rating-from-rbc-capital/ | In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Pennant Group (PNTG), with a price target of $26.00. The company's | Pennant Group (PNTG) Gets a Hold Rating from RBC Capital | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
ANALYSTRATINGS | 2020-04-20 13:34:26 | https://www.analystratings.com/articles/pennant-group-pntg-gets-a-hold-rating-from-rbc-capital/ | In a report released today,
Frank Morgan
from RBC Capital maintained a
Hold
rating on Pennant Group (
PNTG
–
Research Report
), with a price target of
$26.00
. The company’s shares closed last Friday at $19.12.
According to
TipRanks.com
, Morgan is a | Pennant Group (PNTG) Gets a Hold Rating from RBC Capital | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-20 13:34:21 | https://www.smarteranalyst.com/new-blurbs/acadia-healthcare-achc-receives-a-buy-from-rbc-capital/ | In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Acadia Healthcare (ACHC), with a price target of $34.00. The | Acadia Healthcare (ACHC) Receives a Buy from RBC Capital | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
MARKETS | 2020-04-20 13:34:16 | https://www.markets.co/acadia-healthcare-achc-receives-a-buy-from-rbc-capital/248886/ | In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Acadia Healthcare (ACHC – Research | Acadia Healthcare (ACHC) Receives a Buy from RBC Capital | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-20 13:34:12 | https://www.smarteranalyst.com/new-blurbs/rbc-capital-keeps-their-hold-rating-on-fresenius-medical-care-fms/ | In a report released today, Frank Morgan from RBC Capital maintained a Hold rating on Fresenius Medical Care (FMS), with a price target of $42.00. The | RBC Capital Keeps Their Hold Rating on Fresenius Medical Care (FMS) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
ANALYSTRATINGS | 2020-04-20 13:34:08 | https://www.analystratings.com/articles/rbc-capital-keeps-their-hold-rating-on-fresenius-medical-care-fms/ | In a report released today,
Frank Morgan
from RBC Capital maintained a
Hold
rating on Fresenius Medical Care (
FMS
–
Research Report
), with a price target of
$42.00
. The company’s shares closed last Monday at $36.04.
According to
TipRanks.com
, Mor | RBC Capital Keeps Their Hold Rating on Fresenius Medical Care (FMS) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-20 13:34:00 | https://www.smarteranalyst.com/new-blurbs/the-ensign-group-ensg-gets-a-buy-rating-from-rbc-capital/ | In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on The Ensign Group (ENSG), with a price target of $48.00. The company's | The Ensign Group (ENSG) Gets a Buy Rating from RBC Capital | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
ANALYSTRATINGS | 2020-04-20 13:33:56 | https://www.analystratings.com/articles/the-ensign-group-ensg-gets-a-buy-rating-from-rbc-capital/ | In a report released today,
Frank Morgan
from RBC Capital maintained a
Buy
rating on The Ensign Group (
ENSG
–
Research Report
), with a price target of
$48.00
. The company’s shares closed last Monday at $36.88.
According to
TipRanks.com
, Morgan is | The Ensign Group (ENSG) Gets a Buy Rating from RBC Capital | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-20 13:33:49 | https://www.smarteranalyst.com/new-blurbs/rbc-capital-maintains-their-hold-rating-on-davita-dva/ | RBC Capital analyst Frank Morgan maintained a Hold rating on DaVita (DVA) today and set a price target of $75.00. The company's shares closed last Monday | RBC Capital Maintains Their Hold Rating on DaVita (DVA) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
ANALYSTRATINGS | 2020-04-20 13:33:45 | https://www.analystratings.com/articles/rbc-capital-maintains-their-hold-rating-on-davita-dva/ | RBC Capital analyst
Frank Morgan
maintained a
Hold
rating on DaVita (
DVA
–
Research Report
) today and set a price target of
$75.00
. The company’s shares closed last Monday at $77.20.
According to
TipRanks.com
, Morgan is a 5-star analyst with an a | RBC Capital Maintains Their Hold Rating on DaVita (DVA) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-20 13:33:36 | https://www.smarteranalyst.com/new-blurbs/rbc-capital-keeps-their-buy-rating-on-encompass-health-ehc/ | In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Encompass Health (EHC), with a price target of $84.00. The company's | RBC Capital Keeps Their Buy Rating on Encompass Health (EHC) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
ANALYSTRATINGS | 2020-04-20 13:33:32 | https://www.analystratings.com/articles/rbc-capital-keeps-their-buy-rating-on-encompass-health-ehc/ | In a report released today,
Frank Morgan
from RBC Capital maintained a
Buy
rating on Encompass Health (
EHC
–
Research Report
), with a price target of
$84.00
. The company’s shares closed last Monday at $70.47.
According to
TipRanks.com
, Morgan is | RBC Capital Keeps Their Buy Rating on Encompass Health (EHC) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-20 13:33:23 | https://www.smarteranalyst.com/new-blurbs/rbc-capital-keeps-their-buy-rating-on-addus-homecare-adus/ | In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Addus Homecare (ADUS), with a price target of $98.00. The company's | RBC Capital Keeps Their Buy Rating on Addus Homecare (ADUS) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
ANALYSTRATINGS | 2020-04-20 13:33:19 | https://www.analystratings.com/articles/rbc-capital-keeps-their-buy-rating-on-addus-homecare-adus/ | In a report released today,
Frank Morgan
from RBC Capital maintained a
Buy
rating on Addus Homecare (
ADUS
–
Research Report
), with a price target of
$98.00
. The company’s shares closed last Friday at $80.35.
According to
TipRanks.com
, Morgan is a | RBC Capital Keeps Their Buy Rating on Addus Homecare (ADUS) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-20 13:33:11 | https://www.smarteranalyst.com/new-blurbs/lhc-group-lhcg-gets-a-buy-rating-from-rbc-capital-2/ | In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on LHC Group (LHCG), with a price target of $173.00. The company's | LHC Group (LHCG) Gets a Buy Rating from RBC Capital | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-20 13:33:01 | https://www.smarteranalyst.com/new-blurbs/amedisys-amed-receives-a-buy-from-rbc-capital/ | RBC Capital analyst Frank Morgan maintained a Buy rating on Amedisys (AMED) today and set a price target of $218.00. The company's shares closed last | Amedisys (AMED) Receives a Buy from RBC Capital | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-20 13:32:40 | https://www.smarteranalyst.com/new-blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-chemed-che-and-regeneron-regn/ | Analysts have been eager to weigh in on the Healthcare sector with new ratings on Chemed (CHE) and Regeneron (REGN). Chemed (CHE) RBC Capital analyst | Analysts' Opinions Are Mixed on These Healthcare Stocks: Chemed (CHE) and Regeneron (REGN) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
THELINCOLNIANONLINE | 2020-04-19 09:06:41 | https://www.thelincolnianonline.com/2020/04/19/frontier-capital-management-co-llc-has-7-58-million-stock-position-in-acadia-healthcare-company-inc-nasdaqachc.html | Frontier Capital Management Co. LLC reduced its stake in shares of Acadia Healthcare Company Inc (NASDAQ:ACHC) by 2.3% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 413,065 shares of the company’s stock after selling 9,588 shares during the period. Frontier Capital Management Co.... | Frontier Capital Management Co. LLC Has $7.58 Million Stock Position in Acadia Healthcare Company Inc (NASDAQ:ACHC) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
THELINCOLNIANONLINE | 2020-04-18 09:38:42 | https://www.thelincolnianonline.com/2020/04/18/norges-bank-buys-new-shares-in-acadia-healthcare-company-inc-nasdaqachc.html | Norges Bank bought a new stake in Acadia Healthcare Company Inc (NASDAQ:ACHC) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 611,475 shares of the company’s stock, valued at approximately $20,313,000. Norges Bank owned 0.69% of A... | Norges Bank Buys New Shares in Acadia Healthcare Company Inc (NASDAQ:ACHC) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
THEFLY | 2020-04-16 11:10:40 | https://thefly.com/permalinks/entry.php/id3073130/ACAD-Acadia-initiated-with-a-Buy-at-Jefferies | Acadia initiated with a Buy at Jefferies Jefferies ACAD | Acadia initiated with a Buy at Jefferies ACAD | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-15 19:33:03 | https://www.smarteranalyst.com/new-blurbs/analysts-have-conflicting-sentiments-on-these-services-companies-unitedhealth-unh-and-teladoc-tdoc/ | Companies in the Services sector have received a lot of coverage today as analysts weigh in on UnitedHealth (UNH) and Teladoc (TDOC). UnitedHealth (UNH) | Analysts Have Conflicting Sentiments on These Services Companies: UnitedHealth (UNH) and Teladoc (TDOC) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
MARKETS | 2020-04-15 19:32:59 | https://www.markets.co/analysts-have-conflicting-sentiments-on-these-services-companies-unitedhealth-nyse-unh-and-teladoc-nyse-tdoc/248115/ | Companies in the Services sector have received a lot of coverage today as analysts weigh in on UnitedHealth (UNH – | Analysts Have Conflicting Sentiments on These Services Companies: UnitedHealth (NYSE: UNH) and Teladoc (NYSE: TDOC) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-04-15 15:45:10 | https://finance.yahoo.com/news/acadia-healthcare-announces-date-first-154510863.html?.tsrc=rss | FRANKLIN, Tenn. , April 15, 2020 -- Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its first quarter 2020 earnings on Monday, May 4, 2020,. | Acadia Healthcare Announces Date for First Quarter 2020 Earnings Release | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
THELINCOLNIANONLINE | 2020-04-15 11:08:48 | https://www.thelincolnianonline.com/2020/04/15/macquarie-group-ltd-takes-251000-position-in-acadia-healthcare-company-inc-nasdaqachc.html | Macquarie Group Ltd. acquired a new stake in Acadia Healthcare Company Inc (NASDAQ:ACHC) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 7,553 shares of the company’s stock, valued at approximately $251,000. Several other large investors also re... | Macquarie Group Ltd. Takes $251,000 Position in Acadia Healthcare Company Inc (NASDAQ:ACHC) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
THEEPOCHTIMES | 2020-04-15 11:00:44 | https://www.theepochtimes.com/fine-dining-restaurants-find-comforting-ways-to-set-the-table-at-home_3302854.html | Many have put their plating tweezers down and moved molecular gastronomy techniques to the back burner in favor of comforting, soul-nourishing meals. | Fine Dining Restaurants Find Comforting Ways to Set the Table at Home | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga Newsdesk | 2020-04-15 00:00:00 | https://www.benzinga.com/wiim/20/04/15808873/shares-of-several-healthcare-companies-are-trading-lower-amid-overall-market-weakness-caused-by-the | Shares of several healthcare companies are trading lower amid overall market weakness caused by the coronavirus which has decreased consumer spending and economic activity. | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
TELEGRAPH.CO.UK | 2020-04-14 16:57:43 | https://www.telegraph.co.uk/business/2020/04/14/numbers-no-longer-adding-care-homes/ | More than 2,000 care homes in England have reported Covid-19 cases and put for-profit business models under severe strain | Numbers no longer adding up for care homes | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Yahoo | 2020-04-13 19:31:00 | https://finance.yahoo.com/m/0e513e18-673b-3d06-afb1-948cb616dbc7/these-stocks-may-bounce-as.html?.tsrc=rss | DEEP DIVE The Federal Reserve is now buying junk bonds, and analysts at Jefferies argue that presents an opportunity for investors to load up on shares of leveraged companies that are out of favor. The Fed expanded its Secondary Market Corporate Credit Facility on April 9. | These stocks may bounce as the Federal Reserve buys junk bond ETFs, according to Jefferies | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SEEKINGALPHA | 2020-04-13 17:50:48 | https://seekingalpha.com/news/3560243-feds-turn-on-funding-spigot-30b-to-healthcare-providers | Over the past weekend, the U.S. Centers for Medicare & Medicaid Services distributed $30B of the planned $100B in CARES Act grants to healthcare providers as they battle COVID-19.The distribution | Feds turn on funding spigot with $30B to healthcare providers | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
YAHOO | 2020-04-13 16:04:04 | https://finance.yahoo.com/news/mednax-provides-updates-related-coronavirus-160404680.html | MEDNAX (MD) takes several steps to help fight the COVID-19 pandemic. | MEDNAX Provides Updates Related to Coronavirus Pandemic | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
ZACKS | 2020-04-13 16:04:00 | https://www.zacks.com/stock/news/868909/mednax-provides-updates-related-to-coronavirus-pandemic | MEDNAX (MD) takes several steps to help fight the COVID-19 pandemic. | MEDNAX Provides Updates Related to Coronavirus Pandemic | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
SMARTERANALYST | 2020-04-13 11:09:43 | https://www.smarteranalyst.com/new-blurbs/analysts-offer-insights-on-services-companies-ww-grainger-gww-alibaba-baba-and-community-health-cyh/ | Companies in the Services sector have received a lot of coverage today as analysts weigh in on WW Grainger (GWW), Alibaba (BABA) and Community Health | Analysts Offer Insights on Services Companies: WW Grainger (GWW), Alibaba (BABA) and Community Health (CYH) | ACHC | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2023-06-12 08:00:00 | https://www.globenewswire.com/news-release/2023/06/12/2686235/0/en/Achilles-Therapeutics-to-Present-at-Upcoming-Conferences.html | LONDON, June 12, 2023 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, today announced that the Company will be taking part in the following conferences in June: | Achilles Therapeutics to Present at Upcoming Conferences | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2023-05-21 10:03:52 | https://investorplace.com/2023/05/3-stocks-with-1000-upside-potential/ | If you're a risk taker on the lookout for stocks with 1000% upside potential, you'd have to venture into speculative territory. It is difficult to find analyst ratings with such a high upside potential unless catalysts could propel the stock that high. | 3 Stocks With 1,000% Upside Potential | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-02 11:18:40 | https://www.zacks.com/stock/news/2048374/is-achilles-therapeutics-achl-outperforming-other-medical-stocks-this-year | Here is how Achilles Therapeutics PLC Sponsored ADR (ACHL) and Geron (GERN) have performed compared to their sector so far this year. | Is Achilles Therapeutics (ACHL) Outperforming Other Medical Stocks This Year? | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2022-12-20 08:30:00 | https://www.globenewswire.com/news-release/2022/12/20/2577065/0/en/Achilles-Therapeutics-to-Present-at-the-41st-Annual-J-P-Morgan-Healthcare-Conference.html | LONDON, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, today announced that Dr. Iraj Ali, Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Confer... | Achilles Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-12-18 07:14:29 | https://seekingalpha.com/article/4565130-achilles-therapeutics-the-first-full-position-in-my-tax-loss-selling-basket | ACHL has about $4.40 of cash per share on hand, yet it trades below $1. I believe that recent selling is due to tax loss sellers needing to recognize capital loss before the end of the year, and hence their selling is indiscriminate. | Achilles Therapeutics: The First Full Position In My Tax Loss Selling Basket | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2022-11-30 18:05:00 | https://www.globenewswire.com/news-release/2022/11/30/2565493/0/en/Achilles-Therapeutics-to-Present-Early-Proof-of-Concept-of-Safety-and-Clinical-Activity-of-Clonal-Neoantigen-Reactive-T-Cells-at-the-ESMO-Immuno-Oncology-Annual-Congress-2022.html | - Durable partial response (PR) and stable disease (SD) achieved in heavily pre-treated non-small cell lung cancer (NSCLC) patients dosed with cNeT monotherapy - | Achilles Therapeutics to Present Early Proof of Concept of Safety and Clinical Activity of Clonal Neoantigen Reactive T Cells at the ESMO Immuno-Oncology Annual Congress 2022 | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-11-01 13:34:20 | https://www.zacks.com/stock/news/2011981/what-makes-achilles-therapeutics-plc-sponsored-adr-achl-a-new-buy-stock | Achilles Therapeutics PLC Sponsored ADR (ACHL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. | What Makes Achilles Therapeutics PLC Sponsored ADR (ACHL) a New Buy Stock | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2022-05-03 08:00:00 | https://www.globenewswire.com/news-release/2022/05/03/2434471/0/en/Achilles-Therapeutics-to-Present-at-Upcoming-Conferences.html | LONDON, May 03, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that the Company will be taking part in the following conferences in May. | Achilles Therapeutics to Present at Upcoming Conferences | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2022-04-05 08:00:00 | https://www.globenewswire.com/news-release/2022/04/05/2416564/0/en/Achilles-Therapeutics-to-Present-at-Upcoming-Conferences.html | LONDON, April 05, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that management will be taking part in the following conferences in April. | Achilles Therapeutics to Present at Upcoming Conferences | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2022-04-04 08:00:00 | https://www.globenewswire.com/news-release/2022/04/04/2415676/0/en/Achilles-Therapeutics-to-Host-KOL-Webcast-to-Highlight-TRACERx-Study-Presentations-from-the-2022-AACR-Annual-Meeting.html | - Webcast will feature Professor Charles Swanton, TRACERx Chief Investigator and Achilles co-founder - | Achilles Therapeutics to Host KOL Webcast to Highlight TRACERx Study Presentations from the 2022 AACR Annual Meeting | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2022-03-08 08:00:00 | https://www.globenewswire.com/news-release/2022/03/08/2398825/0/en/Achilles-Therapeutics-to-Present-at-the-32nd-Annual-Oppenheimer-Healthcare-Conference.html | LONDON, March 08, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced its participation in the 32nd Annual Oppenheimer Healthcare Conference taking place virtually March 15 - 17, 2022. ... | Achilles Therapeutics to Present at the 32nd Annual Oppenheimer Healthcare Conference | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-12-21 08:00:00 | https://www.globenewswire.com/news-release/2021/12/21/2356050/0/en/Achilles-Therapeutics-to-present-at-the-40th-Annual-J-P-Morgan-Healthcare-Conference.html | LONDON, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that Iraj Ali, Chief Executive Officer, will present at the virtual 40th Annual J.P. Morgan Healthcare Conference on... | Achilles Therapeutics to present at the 40th Annual J.P. Morgan Healthcare Conference | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-11-12 20:36:06 | https://seekingalpha.com/article/4469110-achilles-therapeutics-plc-achl-ceo-iraj-ali-on-sitc-and-corporate-update-call-transcript | Achilles Therapeutics plc (ACHL) CEO Iraj Ali on SITC & Corporate Update Call (Transcript) | Achilles Therapeutics plc (ACHL) CEO Iraj Ali on SITC & Corporate Update Call (Transcript) | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-10-01 08:00:00 | https://www.globenewswire.com/news-release/2021/10/01/2306974/0/en/Achilles-Therapeutics-to-Present-at-Upcoming-Scientific-Congresses.html | LONDON, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, will present an oral presentation at the 2021 European Society for Gene and Cell Therapy (ESGCT) Congress being held in a virtual fo... | Achilles Therapeutics to Present at Upcoming Scientific Congresses | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-09-02 08:30:00 | https://www.globenewswire.com/news-release/2021/09/02/2290879/0/en/Achilles-Therapeutics-to-Present-at-Upcoming-Investor-Conferences.html | LONDON, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that management will present at the following investor conferences in September. | Achilles Therapeutics to Present at Upcoming Investor Conferences | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-08-25 08:00:00 | https://www.globenewswire.com/news-release/2021/08/25/2286262/0/en/Achilles-Therapeutics-Announces-Grant-of-US-and-European-Patents.html | LONDON, Aug. 25, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that US patent US 11,098,121 and European patent EP3347039B have been granted. The patents cover a method of identif... | Achilles Therapeutics Announces Grant of US and European Patents | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-05-03 08:00:00 | https://www.globenewswire.com/news-release/2021/05/03/2221305/0/en/Achilles-Therapeutics-Appoints-Julie-O-Neill-to-Board-of-Directors-and-Markwin-Velders-Ph-D-joins-Scientific-Advisory-Board.html | LONDON, United Kingdom, May 03, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announces the appointment of Julie O'Neill as a Non-Executive Director to the Board and Markwin Velders, Ph.D. ... | Achilles Therapeutics Appoints Julie O'Neill to Board of Directors and Markwin Velders, Ph.D. joins Scientific Advisory Board | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-04-10 08:30:00 | https://www.globenewswire.com/news-release/2021/04/10/2207775/0/en/Achilles-Therapeutics-Demonstrates-cNeT-Product-Characterization-and-Post-Infusion-Tracking-in-a-Patient-Case-Study-at-the-American-Association-for-Cancer-Research-AACR-2021-Annual.html | LONDON, April 10, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today presented a patient case study from the Company's ongoing Phase I/IIa THETIS trial in metastatic or recurrent melanoma at the... | Achilles Therapeutics Demonstrates cNeT Product Characterization and Post-Infusion Tracking in a Patient Case Study at the American Association for Cancer Research (AACR) 2021 Annual Meeting | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-04-06 16:01:00 | https://www.globenewswire.com/news-release/2021/04/06/2205374/0/en/Achilles-Therapeutics-Announces-Closing-of-175-5-million-Initial-Public-Offering.html | LONDON, April 06, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced the closing of its previously announced initial public offering in the United States of 9,750,000 American Deposita... | Achilles Therapeutics Announces Closing of $175.5 million Initial Public Offering | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-04-02 17:56:13 | https://seekingalpha.com/article/4417378-the-ipo-market-slows-with-6-ipos-in-the-shortened-holiday-week | The IPO market pumped the brakes in the shortened holiday week, with six IPOs raising $1.9 billion and just two SPACs raising $300 million. Two blank check companies went public this past week. | U.S. IPO Weekly Recap: The IPO Market Slows With 6 IPOs In The Shortened Holiday Week | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Barrons | 2021-03-31 12:14:00 | https://www.barrons.com/articles/achilles-therapeutics-coursera-stock-trading-debut-51617207202 | Achilles Therapeutics, a biotech developing T-cell therapies for cancer, and Coursera, an educational technology company, are making their public stock market debut. | Achilles Therapeutics and Coursera Open for Trading Today | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Proactive Investors | 2021-03-31 02:43:04 | https://www.proactiveinvestors.co.uk//companies/news/945420/uk-based-achilles-therapeutics-unveils-us1755mln-ipo-at-nasdaq-debut-945420.html?SNAPI | Achilles Therapeutics plc (NASDAQ: ACHL) announced the pricing of its IPO on the Nasdaq that will raise US$175.5mln (£127.8mln). The clinical-stage biopharma, which is developing precision T cell therapies to treat solid tumours, will place 9.7mln American depositary shares (ADSs) at US$18 a pop. | UK-based Achilles Therapeutics unveils US$175.5mln IPO at Nasdaq debut | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-03-30 19:00:00 | https://www.globenewswire.com/news-release/2021/03/30/2202009/0/en/Achilles-Therapeutics-Announces-Pricing-of-Initial-Public-Offering.html | LONDON, March 30, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced the pricing of its initial public offering in the United States of 9,750,000 American Depositary Shares (“ADSs”) re... | Achilles Therapeutics Announces Pricing of Initial Public Offering | ACHL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-07-21 14:32:55 | https://seekingalpha.com/article/4618841-archer-aviation-best-risk-reward-evtol-industry | Archer Aviation Inc., an eVTOL manufacturer, plans to achieve FAA approval for its 'Midnight' aircraft by late 2024, with operations starting in 2025. The company's main partner is Stellantis N.V., which will provide manufacturing technology and a $150 million equity capital line. United Airlines has placed a tentative... | Archer Aviation: The Best Risk/Reward In The eVTOL Industry | ACHR | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-07-19 13:17:04 | https://www.fool.com/investing/2023/07/19/why-archer-aviation-and-joby-aviation-stocks-are-d/ | Archer and Joby are both working to bring "flying taxis" to market, with investors hoping to see revenues by 2025. A new FAA plan to rework the nation's airspace rules by 2028 is causing concerns among investors. | Why Archer Aviation and Joby Aviation Stocks Are Down Today | ACHR | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2023-07-17 07:30:53 | https://investorplace.com/2023/07/3-flying-car-stocks-that-will-skyrocket-before-2025/ | Electric vertical takeoff and landing (eVTOL) aircraft, small aircraft that land and take off like helicopters, are being labeled by some as flying cars. Indeed, they are small like cars and will function in much the same way, since they will take a small number of passengers short distances. | 3 Flying Car Stocks That Will Skyrocket Before 2025 | ACHR | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2023-07-11 17:18:04 | https://investorplace.com/2023/07/3-flying-car-stocks-to-buy-as-the-faa-prepares-for-take-off/ | Flying car stocks are soaring since Alef Aeronautics received a special airworthiness certificate from the Federal Aviation Administration for its Model A. The certification will allow the flight of its vehicle in limited locations for the purposes of exhibition, research and development. | 3 Flying Car Stocks to Buy as the FAA Prepares for Take Off | ACHR | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PennyStocks | 2023-07-10 14:45:50 | https://pennystocks.com/featured/2023/07/10/best-penny-stocks-to-buy-4-to-watch-this-week/ | We've all heard the whispers and rumors about penny stocks. They're often painted as the wild child of the investment world, captivating traders with tales of extreme breakouts and monumental breakdowns. | Best Penny Stocks To Buy? 4 To Watch This Week | ACHR | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-07-07 08:51:43 | https://seekingalpha.com/article/4615704-ev-company-news-for-the-month-of-june-2023 | Global electric car sales for May 2023 were up 50% YoY to 16% share - China sales were up 54% to 35% share, Europe was up 38% to 23% share, USA was up 68% to 8% share. EV market news - Ford, GM and Rivian, Volvo & Polestar to join Tesla's EV charging network. Tesla becomes number 1 for plugin electric car sales in Euro... | EV Company News For The Month Of June 2023 | ACHR | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-07-05 19:22:18 | https://www.fool.com/investing/2023/07/05/why-archer-aviation-stock-soared-almost-15-higher/ | The next-generation aircraft developer hosted a splashy event at its flight test facility. More than 70 members of a key federal agency working group attended. | Why Archer Aviation Stock Soared Almost 15% Higher Today | ACHR | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PennyStocks | 2023-07-05 17:47:31 | https://pennystocks.com/featured/2023/07/05/best-penny-stocks-to-buy-now-3-stocks-with-big-news-in-july/ | Are you looking for the best penny stocks to buy now? You're not alone if this is you. | Best Penny Stocks To Buy Now? 3 Stocks With Big News In July | ACHR | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2023-06-28 14:20:54 | https://investorplace.com/2023/06/why-is-archer-aviation-achr-stock-up-15-today/ | One of today's big movers is Archer Aviation (NYSE: ACHR ). Shares of the electric vertical takeoff and landing (eVOTL) aircraft maker are up approximately 15% in early afternoon trading, as investors pile into ACHR stock on a couple of key announcements. | Why Is Archer Aviation (ACHR) Stock Up 15% Today? | ACHR | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
The Motley Fool | 2023-06-28 14:07:47 | https://www.fool.com/investing/2023/06/28/why-archer-aviation-stock-is-flying-high-today/ | Stellantis just spent $25 million to buy more stock in eVTOL company Archer Aviation. The additional funding will help offset massive cash burn at Archer. | Why Archer Aviation Stock Is Flying High Today | ACHR | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.